Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody—treated liver transplant patients

Gerald McMahon, Paul H. Ehrlich, Zeinab A. Moustafa, Linda A. McCarthy, Diane Dottavio, Mark D. Tolpin, Paul I. Nadler, Lars Östberg – 1 May 1992 – A gene region encoding a segment of the major surface protein, HBsAg, of hepatitis B virus was analyzed from serum samples after orthotopic liver transplantation of three hepatitis B virus chronic carrier patients treated with a human anti—hepatitis B virus monoclonal antibody (SDZ OST 577).

Renal effects in cirrhotic patients with avid sodium retention of atrial natriuretic factor injection during norepinephrine infusion

Salvatore Badalamenti, Gianmario Borroni, Elettra Lorenzano, Pierluigi Incerti, Francesco Salerno – 1 May 1992 – The administration of atrial natriuretic factor to patients with cirrhosis, and avid sodium retention causes marked hypotension and blunted kidney responses.

Changes in bilirubin pigments secreted in bile after liver transplantation

Carl A. Goresky, Ellen R. Gordon, Juan‐Ramon Sanabria, Steven M. Strasberg, M. Wayne Flye – 1 May 1992 – The species of bile pigments secreted in T‐tube fistula bile after liver transplantation were ascertained by high‐performance liquid chromatography in 15 patients for 10 days after liver transplant. Nine glycosidic conjugates and unconjugated bilirubin were resolved by the analytical procedure.

Mirex‐induced adaptive liver growth in rats subjected to thyroidectomy

James D. Yarbrough, Jo M. Grimley, Jaideep V. Thottassery – 1 May 1992 – The organochlorine compound mirex (dodecachlorooctahydro‐1,3,4‐metheno‐2H‐cyclobuta‐CD‐pentalene) induces an adaptive liver growth dependent on the hormonal status of the experimental animal. In the intact laboratory rat, mirex induces liver growth that is an expression of both cellular hyperplasia and hypertrophy. However, in rats subjected to adrenalectomy, mirex induces liver growth that is essentially hyperplastic.

Sequence of exons and the flanking regions of human bilirubin‐UDP‐glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler‐Najjar syndrome, type I

Piter J. Bosma, Namita Roy Chowdhury, Bart G. Goldhoorn, Martin H. Hofker, Ronald P. J. Oude Elferink, Peter L. M. Jansen, Jayanta Roy Chowdhury – 1 May 1992 – Crigler‐Najjar syndrome, type I is a heterogeneous disorder that may result from mutations of various regions of the bilirubin‐UDP‐glucuronosyltransferase gene complex that encodes two bilirubin‐UDP‐glucuronosyltransferase isoforms and a phenol‐UDP‐glucuronosyltransferase isoform in the human liver.

Cholesterol nucleation time in gallbladder bile of patients with solitary or multiple cholesterol gallstones

Dieter Jüngst, Thomas Lang, Christoph von Ritter, Ekkehard Pratschke, Gustav Paumgartner – 1 May 1992 – Patients with multiple cholesterol gallbladder stones have been found to be at a higher risk for the recurrence of gallstones after successful nonsurgical treatment than those with a solitary stone. Cholesterol gallstone recurrence, like primary gallstone formation, probably involves a triple defect with supersaturation, abnormally rapid nucleation of cholesterol in bile and altered gallbladder motor function.

Total effective vascular compliance in patients with cirrhosis: A study of the response to acute blood volume expansion

Antoine Hadengue, Richard Moreau, Christophe Gaudin, Yannick Bacq, Bruno Champigneulle, Didier Lebrec – 1 May 1992 – Although arterial vasodilation is a well‐known feature in patients with cirrhosis, the venous system remains unexplored. To measure total effective vascular compliance, a reflection of the properties of the venous system, rapid volume expansion (300 ml of a gelatin solution in 3 min) was performed in 23 patients. Eleven patients had compensated cirrhosis (Child‐Pugh grade A or B), and eight had decompensated cirrhosis (Child‐Pugh grade C).

Genotype analysis for ΔF508, G551D and R553X mutations in children and young adults with cystic fibrosis with and without chronic liver disease

Ann Duthie, Derek G. Doherty, Carolyn Williams, Robert Scott‐Jupp, J. O. Warner, M. Stuart Tanner, Robert Williamson, Alex P. Mowat – 1 April 1992 – Genetic factors have been implicated in the pathogenesis of liver disease in cystic fibrosis. To investigate whether liver disease is associated with particular mutations of the defective gene in cystic fibrosis, we have determined the frequencies of three mutations – ΔF508, G551D and R553X – in 111 children and young adults with cystic fibrosis by analysis of genomic DNA segments amplified by the polymerase chain reaction.

Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced cirrhosis

Francesco Violi, Domenico Ferro, Stefania Basili, Claudio Quintarelli, Mirella Saliola, Cesare Alessandri, Corrado Cordova, Francesco Balsano – 1 April 1992 – Sixty‐one patients with different degrees of liver failure, 23 with Child‐Pugh class B and 38 with Child‐Pugh class C, were studied and observed for 3 yr. Coagulation index analysis showed significantly lower values of prothrombin activity, more prolonged activated partial thromboplastin time, higher bilirubin and fibrinogen degradation products values in class C patients.

Subscribe to